Physician profile
Hannah M Painter
NPI 1346739935
$1,178.94
in general payments reported to CMS, 2019-2025
15 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.71 · 2021: $29.62 · 2022: $65.85 · 2023: $80.15 · 2024: $493 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.30 | 2022-2025 | Qulipta, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $135.88 | 2020-2025 | |
| Astellas Pharma US INC | $123.08 | 2023-2025 | Veozah |
| Pfizer INC. | $121.98 | 2024-2025 | |
| Novo Nordisk INC | $92.27 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $46.71 | 2023-2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $42.01 | 2021-2025 | |
| Amgen INC. | $40.79 | 2022-2025 | Evenity, Prolia |
| Insulet Corporation | $16.99 | 2021 | |
| Daiichi Sankyo INC. | $15.91 | 2024 | Injectafer |
| Glaxosmithkline, LLC. | $15.86 | 2022 | |
| Lundbeck LLC | $15.09 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $13.95 | 2025 | Eliquis |
| Vanda Pharmaceuticals INC. | $13.73 | 2025 | Fanapt |
| Lilly USA, LLC | $13.39 | 2024 | Jardiance, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Painter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.